Search Options Stock News and Analysis from Schaeffer's

PBYI Stock Plunges After Goldman Screams "Sell"

https://www.schaeffersresearch.com/content/news/2019/10/08/pbyi-stock-plunges-after-goldman-screams-sell

10/8/2019 9:56 AM

Goldman Sachs downgraded Puma Biotechnology Inc (NASDAQ:PBYI) stock to "sell" from "neutral," and slashed its price target to $8 from $24 -- a 20.6% discount to last night's close. The brokerage firm...

Put Options In Play For This Drug Stock

https://www.schaeffersresearch.com/content/analysis/2019/09/05/put-options-in-play-for-this-drug-stock

9/5/2019 11:55 AM

The shares of Puma Biotechnology Inc (NASDAQ:PBYI) are enjoying a mini-rally today, up 3.1% to trade at $10.71 at last check. The drug stock has added 17% in the past month, but this has taken PBYI ri...

Options Volume Spikes on Sinking Drug Stock

https://www.schaeffersresearch.com/content/options/2019/04/01/options-volume-spikes-on-sinking-drug-stock

4/1/2019 2:36 PM

The shares of Puma Biotechnology Inc (NASDAQ:PBYI) are down 9.3% to trade at $35.29, one of the worst stocks on the Nasdaq today, after the company inked an exclusive licensing deal with Pierre Fabre ...

Puma Biotechnology Attempts a Rebound After Drug Win

https://www.schaeffersresearch.com/content/news/2018/12/18/puma-biotechnology-attempts-a-rebound-after-drug-win

12/18/2018 10:33 AM

Shares of Puma Biotechnology Inc (NASDAQ:PBYI) are up 6.9% at $22.90, after the company announced successful results of the Phase III NALA trial for its experimental breast cancer drug, neratinib. An...

Stocks Bounce Back on Trade Hope, Facebook Earnings

https://www.schaeffersresearch.com/content/news/2018/11/02/stocks-bounce-back-on-trade-hope-facebook-earnings

11/2/2018 1:37 PM

Stocks came back with a bang this week, though it wasn't enough to save the Dow from its worst monthly loss since January 2016. While news the U.S. was considering more tariffs on Chinese goods spoo...

PEOPLE ALSO SEARCH FOR